DR
Daniel Raskas (SVP - Corporate Development) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Danaher Corporation (DHR). The largest single filing was $8.2M of DHR (34,688 sh across 2 lots, as filed), executed Nov 25 2024. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 26 2024
Filed Nov 27 2024
Median ADV $1.0B across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
DHRRecent filings
DHRSALE
Danaher Corporation
View filing →
$8.2M34,688 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET